TABLE 1.

Proportion of Patients With Optimal BP at Different Time Points

	Proportion With Optimal BP			Relative Risk
	Prior	Baseline	6 mo	Baseline to Prior	6 mo to Baseline	ARR	NNT
Methotrexate	0.48	0.47	0.51	0.97	1.09a	0.043	23
Prednisone	0.47	0.46	0.50	0.98	1.08a	0.036	28
Leflunomide	0.49	0.48	0.47	0.98	0.97	−0.014	−71
TNFi	0.47	0.47	0.49	0.99	1.05b	0.023	43
Sulfasalazine	0.49	0.48	0.48	0.99	1.00	−0.001	−1000
Hydroxychloroquine	0.50	0.49	0.53	0.99	1.07a	0.036	28

Also provided are the RR before and after initiation of therapy, the absolute risk reduction, and the number needed to treat.

^aP < 0.0001.

^bP < 0.05.

ARR indicates absolute risk reduction; NNT, number needed to treat; RR, relative risk.